The Pharma Product Management Trap That Confuses Doctors | The 60,000 Brand Saturation Trap

How does a pharmaceutical giant navigate a market where 60,000 generic brands are launched every single year?

In this exclusive trailer, Dr. Vijay Charlu (President - India Business, CORONA Remedies Limited) exposes the harsh realities of product line saturation and the boardroom strategies used to build a highly defensive medicine portfolio.

Discover why standard asset-heavy pharmaceutical models fall into the internal "rat race" trap by launching copycat molecules across overlapping divisions and learn the exact three-pronged molecule selection framework required to capture true sustainable market share.

📊 Key Strategy Matrices Covered in This Preview:
The Saturation Trap: Navigating a market crowded by thousands of copycat launches.
The Build vs. Buy Equation: Deciding between a completely fresh launch, an intentional brand acquisition, or a strategic product line extension.
The Line Principle: Emphasizing internal focus and deep specialization—"Apna line bada karo, doosre ka line dekhne mat."

Stay tuned, the full masterclass episode will be releasing soon!

Make sure to Subscribe to Game of Pharma and hit the notification bell so you don't miss the absolute deep-dive strategy drop!

#PharmaPodcast #BusinessStrategy #ProductPortfolio #GameOfPharma #LifeSciences #PharmaMarketing #CorporateLeadership #GenericMedicines #CoronaRemedies #ExecutiveMasterclass #indianpharmacist

{Pharma Portfolio Strategy, Molecule Selection Matrix, Corona Remedies Case Study, Generic Medicine Brand Launch, India Pharmaceutical Business, Dr Vijay Charlu Masterclass, Game Of Pharma, Product Management Trap, Medical Reps, Indian Pharma, Pharma Business, Pharma Podcast, Pharmacists}

Видео The Pharma Product Management Trap That Confuses Doctors | The 60,000 Brand Saturation Trap канала Game Of Pharma